Nanalysis Scientific Corp.

Equities

NSCI

CA63000Y1034

Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 09:30:00 2024-05-23 EDT			5-day change	1st Jan Change
0.47 ^CAD	+1.08%		+4.44%	+25.33%

04-30	Transcript : Nanalysis Scientific Corp., 2023 Earnings Call, Apr 30, 2024
04-29	Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Nanalysis Scientific Corp. Provides Revenue Guidance for the Third Quarter Ended September 30, 2022

October 20, 2022 at 08:30 am

Nanalysis Scientific Corp. provided revenue guidance for the third quarter ended September 30, 2022. The Company looks to report gross revenues for the third quarter ended September 30, 2022, of at least $6.8 million, representing an increase of over 100% year over year.

Latest news about Nanalysis Scientific Corp.

Transcript : Nanalysis Scientific Corp., 2023 Earnings Call, Apr 30, 2024	04-30
Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Transcript : Nanalysis Scientific Corp., Q4 2023 Earnings Call, Apr 29, 2024	04-29
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director	04-10	CI
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances	04-04	CI
Nanalysis Scientific Corp. announced that it has received CAD 1 million in funding	03-19	CI
Nanalysis Scientific Announces Financings	03-06	MT
Nanalysis Scientific Brief: Announcing Up to $5 Million 'Best Efforts Prospectus Exempt Offering' Pursuant to the Listed Issuer Exemption and Up to $1 Million Concurrent Private Placement	03-06	MT
Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding	03-05	CI
Nanalysis Scientific Corp. to Seeks Acquisitions	02-13	CI
Transcript : Nanalysis Scientific Corp. - Special Call	02-13
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023	02-06	CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 30, 2023	11-30
Nanalysis Scientific Third-Quarter Loss Widens as Sales Rise	11-29	MT
Nanalysis Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
Transcript : Nanalysis Scientific Corp., Q3 2023 Earnings Call, Nov 29, 2023	11-29
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 25, 2023	23-08-25
Transcript : Nanalysis Scientific Corp., Q2 2023 Earnings Call, Aug 24, 2023	23-08-24
Nanalysis Scientific Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Nanalysis Scientific Enters into New Credit Facility with ATB Financial	23-06-30	MT
Transcript : Nanalysis Scientific Corp. - Shareholder/Analyst Call	23-06-28
Transcript : Nanalysis Scientific Corp. - Special Call	23-06-21
Transcript : Nanalysis Scientific Corp., Q1 2023 Earnings Call, May 25, 2023	23-05-25
Nanalysis Scientific Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding	23-05-02	CI

Chart Nanalysis Scientific Corp.

Duration

Period

More charts

Company Profile

Nanalysis Scientific Corp. is a Canada-based patent-protected technology company that develops, manufactures and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. The Company operates through four segments: Nanalysis, RS2D, KâPrime and Corporate. The Companyâs subsidiaries include Nanalysis Corp., Nanalysis GmbH, RS2D S.A.S., One Moon Scientific (OMS), K'(Prime) Technologies Inc., KPrime Group USA, KPrime Technologies, Quad Systems AG and Quad Systems Ltd. RS2D S.A.S. is a technology company that is specialized in the designing of compact, electronics components for a range of precision analytical MR instruments, including both NMR and magnetic resonance imaging (MRI). OMS is a software company, which is specialized in a suite of software tools to streamline and automate magnetic resonance data analysis and management.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.465 CAD

Average target price

1.2 CAD

Spread / Average Target

+158.06%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NANALYSIS SCIENTIFIC CORP.	+25.33%	38.44M
THERMO FISHER SCIENTIFIC	+10.92%	226B
DANAHER CORPORATION	+14.83%	198B
INTUITIVE SURGICAL, INC.	+19.88%	142B
BOSTON SCIENTIFIC CORPORATION	+30.51%	111B
SIEMENS HEALTHINEERS AG	+2.09%	65.26B
EDWARDS LIFESCIENCES CORPORATION	+16.49%	54.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	50.94B
AGILENT TECHNOLOGIES, INC.	+9.56%	44.8B
GE HEALTHCARE TECHNOLOGIES INC.	+4.40%	36.8B

Other Advanced Medical Equipment & Technology